StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly geographic revenue — United States ($M) ($M)

Form 10-Q / 10-K Note 2 & MD&A

Latest, FY2025
43,481
Period ended Dec 31, 2025
Change on a year earlier
+43.1%
30,375 in FY2024
History
16 years
Since FY2010
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGeographic revenue — United States ($M) ($M)Year on yearSource
FY2025Dec 31, 202543,481+43.1%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 202430,375+39.4%Form 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 202321,791+19.8%Form 10-K (filed 2026-02-12) ↗
FY2022Dec 31, 202218,190+8.2%Form 10-K (filed 2025-02-19) ↗
FY2021Dec 31, 202116,811+18.1%Form 10-K (filed 2024-02-21) ↗
FY2020Dec 31, 202014,229+11.8%Form 10-K (filed 2023-02-22) ↗
FY2019Dec 31, 201912,723+2.7%Form 10-K (filed 2022-02-23) ↗
FY2018Dec 31, 201812,392+8.6%Form 10-K (filed 2021-02-17) ↗
FY2017Dec 31, 201711,414+14.8%Form 10-K (filed 2020-02-19) ↗
FY2016Dec 31, 20169,942-1.5%Form 10-K (filed 2019-02-19) ↗
FY2015Dec 31, 201510,097+10.5%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 20149,134-29.1%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 201312,890+4.7%Form 10-K (filed 2015-02-19) ↗
FY2012Dec 31, 201212,313-5.1%Form 10-K (filed 2015-02-19) ↗
FY2011Dec 31, 201112,977+0.9%Form 10-K (filed 2013-02-21) ↗
FY2010Dec 31, 201012,866–Form 10-K (filed 2013-02-21) ↗

Cite this data

StockData. (2026). Eli Lilly Geographic revenue — United States ($M) ($M), annual FY2010–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev_geo_us

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.